Article

Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution.

Structural Genomics Consortium, University of Oxford, Botnar Research Centre, Oxford, United Kingdom.
Proteins Structure Function and Bioinformatics (impact factor: 3.39). 07/2006; 63(4):1132-6. DOI:10.1002/prot.20958
Source: PubMed
0 0
 · 
0 Bookmarks
 · 
36 Views
  • Source
    Article: Large-scale structural analysis of the classical human protein tyrosine phosphatome.
    Alastair J Barr, Emilie Ugochukwu, Wen Hwa Lee, Oliver N F King, Panagis Filippakopoulos, Ivan Alfano, Pavel Savitsky, Nicola A Burgess-Brown, Susanne Müller, Stefan Knapp
    [show abstract] [hide abstract]
    ABSTRACT: Protein tyrosine phosphatases (PTPs) play a critical role in regulating cellular functions by selectively dephosphorylating their substrates. Here we present 22 human PTP crystal structures that, together with prior structural knowledge, enable a comprehensive analysis of the classical PTP family. Despite their largely conserved fold, surface properties of PTPs are strikingly diverse. A potential secondary substrate-binding pocket is frequently found in phosphatases, and this has implications for both substrate recognition and development of selective inhibitors. Structural comparison identified four diverse catalytic loop (WPD) conformations and suggested a mechanism for loop closure. Enzymatic assays revealed vast differences in PTP catalytic activity and identified PTPD1, PTPD2, and HDPTP as catalytically inert protein phosphatases. We propose a "head-to-toe" dimerization model for RPTPgamma/zeta that is distinct from the "inhibitory wedge" model and that provides a molecular basis for inhibitory regulation. This phosphatome resource gives an expanded insight into intrafamily PTP diversity, catalytic activity, substrate recognition, and autoregulatory self-association.
    Cell 02/2009; 136(2):352-63. · 32.40 Impact Factor
  • Article: PTPN14 is required for the density-dependent control of YAP1.
    Wenqi Wang, Jun Huang, Xin Wang, Jingsong Yuan, Xu Li, Lin Feng, Jae-Il Park, Junjie Chen
    [show abstract] [hide abstract]
    ABSTRACT: Through an shRNA-mediated loss-of-function screen, we identified PTPN14 as a potential tumor suppressor. PTPN14 interacts with yes-associated protein 1 (YAP1), a member of the hippo signaling pathway. We showed that PTPN14 promotes the nucleus-to-cytoplasm translocation of YAP1 during contact inhibition and thus inhibits YAP1 transactivation activity. Interestingly, PTPN14 protein stability was positively controlled by cell density. We identified the CRL2(LRR1) (cullin2 RING ubiquitin ligase complex/leucine-rich repeat protein 1) complex as the E3 ligase that targets PTPN14 for degradation at low cell density. Collectively, these data suggest that PTPN14 acts to suppress cell proliferation by promoting cell density-dependent cytoplasmic translocation of YAP1.
    Genes & development 09/2012; 26(17):1959-71. · 12.08 Impact Factor
  • Article: Protein tyrosine phosphatase non-receptor type 14 is a novel sperm-motility biomarker.
    Hsin-Chih Albert Chao, Chia-Ling Chung, Hsien-An Pan, Pao-Chi Liao, Pao-Lin Kuo, Chao-Chin Hsu
    [show abstract] [hide abstract]
    ABSTRACT: To understand the molecular basis of sperm-motility and to identify related novel motility biomarkers. Two-dimensional electrophoresis (2DE) followed by Reverse-phase-nano-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry (RP-nano-HPLC-ESI-MS/MS) were applied to establish the human sperm proteome. Then the sperm proteome of moderate-motile human sperm fraction and that of good-motile human sperm fraction from pooled spermatozoa of forty normozoospermic donors (Group 1 subjects) were compared to identify the dysregulated proteins. Among these down-regulated proteins, Protein tyrosine phosphatase non-receptor type 14 (PTPN14) was chosen to reconfirm by Western blotting and semi-quantitative reverse transcription polymerase chain reaction. For clinical application, Western blotting and real-time reverse transcription polymerase chain reaction was performed to compare the expression level of PTPN14 in (Group 2 subjects) nine normozoospermic controls and thirty-three asthenozoospermic patients (including 21 mild asthenozoospermic cases and 12 severe cases). Finally, bioinformatic tools prediction and immunofluorescence assay were performed to elucidate the potential localization of PTPN14. The expression levels of three proteins were observed to be lower in the moderate-motile sperm fraction than in good-motile sperm of group 1 subjects. Among three proteins with persistent down-regulation in the moderate-motile sperm, we reconfirmed that the expression level of PTPN14 was significantly lower in both mRNA and protein levels from the moderate-motile sperm fraction. Further, down-regulation of PTPN14 was found at the translational and transcriptional level in the asthenozoospermic men. Finally, Bioinformatic tools prediction and immunofluorescence assay showed that PTPN14 maybe predominantly localized at the mitochondria in the midpiece of human ejaculated sperm. Proteomics tools were applied to identify three possible sperm motility-related proteins. Among these proteins, PTPN14 was highly likely a novel sperm-motility biomarker and a potential mitochondrial protein.
    Journal of Assisted Reproduction and Genetics 06/2011; 28(9):851-61. · 1.84 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.